Studies vaspin gene variants and vaspin levels in people with psoriasis
Compares a vaspin gene variant and blood vaspin levels in adults with psoriasis.
Plain-language title generated from the registry record
Registry title: Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
Key facts
- Where
- Aswān, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Source: NCT07320872, who can take part
Where in Egypt
- Aswan University HospitalAswān, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aswan University
- Trial code
- NCT07320872
- Record updated
- 6 January 2026
- Original description
Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people.Read full original descriptionShow less
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris and Its Relation to Pathogenesis and Risk of the Disease
Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people.
It is associated with poor quality of life, reduced life expectancy and multimorbidity including psoriatic arthritis, obesity and cardiovascular disease.
Vaspin (VASP, SERPIN 12) is a recently discovered adipokine that has been isolated from the visceral adipose tissue of a rat model of type 2 diabetes. It is coded by the gene SERPNA12 located on the long arm of chromosome 14q32.13 and consists of six exons and five introns.
Inclusion: Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients; Pateints with any age and gender.
Exclusion: Patients with chronic diseases: cardiac diseases, hepatic disorders, chronic renal failure or malignancies; Patients with associated inflammatory disease such as infections and autoimmune diseases; Pregnancy and lactation.